<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30241262</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">2378-9506</ISSN>                <JournalIssue CitedMedium="Internet">                    <Issue>4</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of global oncology</Title>                <ISOAbbreviation>J Glob Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>Estimates of Cancer Incidence in Ethiopia in 2015 Using Population-Based Registry Data.</ArticleTitle>            <Pagination>                <MedlinePgn>1-11</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1200/JGO.17.00175</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Noncommunicable diseases, prominently cancer, have become the second leading cause of death in the adult population of Ethiopia. A population-based cancer registry has been used in Addis Ababa (the capital city) since 2011. Availability of up-to-date estimates on cancer incidence is important in guiding the national cancer control program in Ethiopia.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">We obtained primary data on 8,539 patients from the Addis Ababa population-based cancer registry and supplemented by data on 1,648 cancer cases collected from six Ethiopian regions. We estimated the number of the commonest forms of cancer diagnosed among males and females in Ethiopia and computed crude and age-standardized incidence rates.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">For 2015 in Ethiopia, we estimated that 21,563 (95% CI, 17,416 to 25,660) and 42,722 (95% CI, 37,412 to 48,040) incident cancer cases were diagnosed in males and females, respectively. The most common adult cancers were: cancers of the breast and cervix, colorectal cancer, non-Hodgkin lymphoma, leukemia, and cancers of the prostate, thyroid, lung, stomach, and liver. Leukemia was the leading cancer diagnosis in the pediatric age group (age 0 to 14 years). Breast cancer was by far the commonest cancer, constituting 33% of the cancers in women and 23% of all cancers identified from the Addis Ababa cancer registry. It was also the commonest cancer in four of the six Ethiopian regions included in the analysis. Colorectal cancer and non-Hodgkin lymphoma were the commonest malignancies in men.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Cancer, and more prominently breast cancer, poses a substantial public health threat in Ethiopia. The fight against cancer calls for expansion of population-based registry sites to improve quantifying the cancer burden in Ethiopia and requires both increased investment and application of existing cancer control knowledge across all segments of the Ethiopian population.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Memirie</LastName>                    <ForeName>Solomon Tessema</ForeName>                    <Initials>ST</Initials>                    <AffiliationInfo>                        <Affiliation>Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret Woldetinsae Abraha, Harar General Hospital, Harar; Girma Ababi, Hawassa University, Hawassa, Ethiopia; and Ahmedin Jemal, American Cancer Society, Atlanta, GA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Habtemariam</LastName>                    <ForeName>Mahlet Kifle</ForeName>                    <Initials>MK</Initials>                    <AffiliationInfo>                        <Affiliation>Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret Woldetinsae Abraha, Harar General Hospital, Harar; Girma Ababi, Hawassa University, Hawassa, Ethiopia; and Ahmedin Jemal, American Cancer Society, Atlanta, GA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Asefa</LastName>                    <ForeName>Mathewos</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret Woldetinsae Abraha, Harar General Hospital, Harar; Girma Ababi, Hawassa University, Hawassa, Ethiopia; and Ahmedin Jemal, American Cancer Society, Atlanta, GA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Deressa</LastName>                    <ForeName>Biniyam Tefera</ForeName>                    <Initials>BT</Initials>                    <AffiliationInfo>                        <Affiliation>Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret Woldetinsae Abraha, Harar General Hospital, Harar; Girma Ababi, Hawassa University, Hawassa, Ethiopia; and Ahmedin Jemal, American Cancer Society, Atlanta, GA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Abayneh</LastName>                    <ForeName>Getamesay</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret Woldetinsae Abraha, Harar General Hospital, Harar; Girma Ababi, Hawassa University, Hawassa, Ethiopia; and Ahmedin Jemal, American Cancer Society, Atlanta, GA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tsegaye</LastName>                    <ForeName>Biniam</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret Woldetinsae Abraha, Harar General Hospital, Harar; Girma Ababi, Hawassa University, Hawassa, Ethiopia; and Ahmedin Jemal, American Cancer Society, Atlanta, GA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Abraha</LastName>                    <ForeName>Mihiret Woldetinsae</ForeName>                    <Initials>MW</Initials>                    <AffiliationInfo>                        <Affiliation>Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret Woldetinsae Abraha, Harar General Hospital, Harar; Girma Ababi, Hawassa University, Hawassa, Ethiopia; and Ahmedin Jemal, American Cancer Society, Atlanta, GA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ababi</LastName>                    <ForeName>Girma</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret Woldetinsae Abraha, Harar General Hospital, Harar; Girma Ababi, Hawassa University, Hawassa, Ethiopia; and Ahmedin Jemal, American Cancer Society, Atlanta, GA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jemal</LastName>                    <ForeName>Ahmedin</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret Woldetinsae Abraha, Harar General Hospital, Harar; Girma Ababi, Hawassa University, Hawassa, Ethiopia; and Ahmedin Jemal, American Cancer Society, Atlanta, GA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rebbeck</LastName>                    <ForeName>Timothy R</ForeName>                    <Initials>TR</Initials>                    <AffiliationInfo>                        <Affiliation>Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret Woldetinsae Abraha, Harar General Hospital, Harar; Girma Ababi, Hawassa University, Hawassa, Ethiopia; and Ahmedin Jemal, American Cancer Society, Atlanta, GA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Verguet</LastName>                    <ForeName>Stéphane</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret Woldetinsae Abraha, Harar General Hospital, Harar; Girma Ababi, Hawassa University, Hawassa, Ethiopia; and Ahmedin Jemal, American Cancer Society, Atlanta, GA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Glob Oncol</MedlineTA>            <NlmUniqueID>101674751</NlmUniqueID>            <ISSNLinking>2378-9506</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA Oncol. 2017 Apr 1;3(4):524-548</RefSource>                <PMID Version="1">27918777</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Prostate Cancer. 2013;2013:560857</RefSource>                <PMID Version="1">23476788</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Prev Chronic Dis. 2012;9:E84</RefSource>                <PMID Version="1">22498035</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Res Notes. 2015 Sep 24;8:474</RefSource>                <PMID Version="1">26404043</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2009 Mar;45(5):756-64</RefSource>                <PMID Version="1">19128954</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol. 2016 Sep;44 Suppl 1:S23-S42</RefSource>                <PMID Version="1">27678320</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17</RefSource>                <PMID Version="1">24639052</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA Oncol. 2015 Jul;1(4):505-27</RefSource>                <PMID Version="1">26181261</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2015;16(7):2757-61</RefSource>                <PMID Version="1">25854359</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2016;17(S3):43-6</RefSource>                <PMID Version="1">27165206</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ecancermedicalscience. 2014 May 06;8:426</RefSource>                <PMID Version="1">24834121</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2016 Apr 28;374(17):1605-7</RefSource>                <PMID Version="1">27119236</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2009 Jul 15;125(2):253-6</RefSource>                <PMID Version="1">19384945</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Glob Health Action. 2014 Oct 29;7:25550</RefSource>                <PMID Version="1">25377338</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103</RefSource>                <PMID Version="1">24488779</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2008 Oct 15;113(8 Suppl):2366-71</RefSource>                <PMID Version="1">18837032</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2015 Mar;65(2):87-108</RefSource>                <PMID Version="1">25651787</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Glob Health Sci Pract. 2016 Mar 25;4(1):87-98</RefSource>                <PMID Version="1">27016546</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1174-82</RefSource>                <PMID Version="1">19293308</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2013 Jul;49(11):2555-64</RefSource>                <PMID Version="1">23597721</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pediatr Blood Cancer. 2009 May;52(5):559-65</RefSource>                <PMID Version="1">19127567</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2011 Apr;12(4):387-98</RefSource>                <PMID Version="1">21463833</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30241262</ArticleId>            <ArticleId IdType="doi">10.1200/JGO.17.00175</ArticleId>            <ArticleId IdType="pmc">PMC6223441</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>